Rep. Porter Honored For Work on Budget

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 5
Volume 5
Issue 5

WASHINGTON--Representative John Edward Porter of Illinois has received an American Academy of Otolaryngology--Head and Neck Surgery, Inc. award for "superb legislative leadership for medical research."

WASHINGTON--Representative John Edward Porter of Illinois hasreceived an American Academy of Otolaryngology--Head and NeckSurgery, Inc. award for "superb legislative leadership formedical research."

Rep. Porter, in his first year as chairman of the House of Representative'sSubcommittee on Labor-HHS-Education and Other Related Agencies,succeeded in extricating medical research funding from the overallbudget battle, thus assuring continuation of medical researchat medical centers and universities throughout the country.

In presenting the award, Robert J. Ruben, MD, professor of pediatrics,Albert Einstein College of Medicine of the Yeshiva Universityand Montefiore Medical Center, New York City, said that Rep. Porter'sleadership "allows vital research work . . . to go forwarduninterrupted . . . not only in our field, but also in the fieldsof cancer, heart disease, and lung disease--indeed in all healthareas of profound interest to the American people, and peopleworldwide."

Recent Videos
Two experts are featured in this series.
Two experts are featured in this series.
Sonia Jain, PhD, stated that depatuxizumab mafodotin, ABBV-221, and ABBV-321 were 3 of the most prominent ADCs in EGFR-amplified glioblastoma.
2 experts are featured in this series.
2 experts are featured in this series.
Skin toxicities are common with targeted therapies for GI malignancies but can be remedied by preventative measures and a collaboration with dermatology.
Computational models help researchers anticipate how ADCs may behave in later lines of development, while they are still in the early stages.
2 experts are featured in this series.